JENNIFER LEE: Open Payments
NPI 1669531935 · IOWA CITY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 15 payments from 7 companies in 2025. Trend: 2023 $815 · 2024 $343 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| BridgeBio Pharma, Inc. | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| PFIZER INC. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: FARXIGA, Attruby, LEQVIO, Kerendia, JARDIANCE, VYNDAQEL, EVKEEZA, ENTRESTO.
Industry payments across IA — which companies pay providers there.
